Sweet Dreams Ahead: FDA Approves Zepbound for the Treatment of Sleep Apnea!
FDA Approves Zepbound: A New Hope for Sleep Apnea Relief
semaglutide, tirzepatide, ozempic, wegovy, zepbound, mounjaro, liraglutide, and saxenda
On Thursday, 12/19/2024, the FDA declared that tirzepatide (Zepbound / Mounjaro) is no longer in shortage. This will have significant impact for patients currently being treated with compounded tirzepatide. Read on to learn more about this decision, and about your…